Latest News

Dow Jones Newswires: VTv Therapeutics slashes 65% of workforce, focuses on its diabetes drug

VTv Therapeutics Inc. said it reduced its workforce by about 65% as it prioritizes development of diabetes drug TTP399.

You may also like

Leave a reply

Your email address will not be published.

More in Latest News